33rd International Symposium on Pharmaceutical and Biomedical Analysis (PBA2023) , Ankara, Türkiye, 2 - 06 Temmuz 2023, cilt.1, sa.1, ss.150, (Özet Bildiri)
Entecavir and Tenofovir, nucleos(t)ide analogs (NUCs), the
combination is recommended first-line therapy in multidrug-resistant
hepatitis B patients due to good tolerance, lower side-effect
profile, and high genetic barrier. This study reports the fabrication
of a novel polymer resin and graphene-modified carbon paste electrodes
for the simultaneous determination of the anti-HBV drugs entecavir (ETV) and tenofovir (TEV) in bulk and dosage form by
differential pulse voltammetry (DPV). The electrodes were specified
through cyclic voltammetry, and scanning electron microscopy
(SEM), and the analytical parameters were optimized. Both
drugs displayed clear oxidation peaks on the polymer resin and
graphene-modified carbon paste electrodes in the Britton-Robinson
buffer. The proposed method was successfully applied to the
simultaneous determination of ETV and TEV in commercial tablet
dosage forms, exhibiting good accuracy and precision. Moreover,
the addition of many excipients in the simultaneous analyzes
of TEN and ENT confirmed the anti-interference properties of
the fabricated sensors, as they did not affect the electrochemical
behavior of the substances.